CompletedPhase 1

The Effect of Platelet Rich Plasma (PRP) Application on Rotator Cuff Tear.

Greece40 participantsStarted 2022-12-23

Plain-language summary

The aim of this randomized control trial is to evaluate the impact and effectiveness of PRP on tenocyte metabolism and tendon tissue properties in rotator cuff tear.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Full thickness rotator cuff tear treated with arthroscopic repair * Age of 18 to 65 years * Chronic shoulder pain due to rotator cuff tear * Magnetic resonance imaging study within 6 months prior to arthroscopy * Goutallier grade 1 or 2 muscle fatty infiltration Exclusion Criteria: * Comorbidities, including coagulopathy, liver disease, cancer, nutritional disorder * Goutallier grade 3 or 4 muscle fatty infiltration * Shoulder osteoarthritis, rotator cuff arthropathy, rheumatoid arthritis * History oof shoulder injection within the last 12 months * History of prior shoulder surgery

What they're measuring

Movin score

Timeframe: Immediately after surgery.

Trial details

NCT IDNCT07456215

SponsorAristotle University Of Thessaloniki

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-13

View on ClinicalTrials.gov More Tendon Injuries trials